The most viewed healthcare terms
The terms and definitions that have received the most views since we launched the PMliVE Glossary.
The legal right of exclusive use and license granted by a government to the person who invents something. Pharmaceutical Patents nominally last for 20 years but the effective patent life is much lower because patents are typically granted years before a product has cleared review and been granted a license
- Affinity marketing
Marketing targeted at individuals sharing common interests that predispose them towards a product, eg, a company marketing a calcium antagonist through a specialist cardiology journal.
Also, a campaign jointly sponsored by a number of disparate organisations that are non-competitive but have a common interest
- Alpha/beta testing
Systems for checking the likely success of a new product. Alpha relates to the internal testing and beta to the tests carried out in the marketplace
- Acute care
Treatment of a disease or illness, or following an accident or trauma, which is brief but severe.
- Medicines and Healthcare products Regulatory Agency (MHRA)
An executive agency of the Department of Health that is responsible for ensuring that medicines and medical devices work, and are acceptably safe
- Market challenger
A company already holding a major share in the market and competing with the current market leader
- Above the fold
Originally applied to printed media, the term is used to indicate whether a banner ad or other content is displayed on a web page without the need to scroll. In the event of adverts, appearing above the fold is more likely to give higher clickthrough rates. The location of 'the fold' within the web browser is dependent on the screen resolution of the user's computer
- Clinical trial
A clinical trial is a research study into a new therapies, vaccines or new ways of using known treatments to determine the safety and efficacy of a drug before it reaches the public. Clinical trials are also referred to as medical research or research studies.
Trials are conducted in four phases with an increasing number of patients enrolled at each phase:
Phase I – involves a small number of participants and tests the actions of the drug in humans
Phase II – evaluates the drug for a particular indicated use
Phase III – gathers additional evidence on a drug once preliminary effectiveness has been proved
Phase IV – ongoing research after the drug has gone to market
Written content, eg, statement of opinion from an author about a specific subject or news coverage
The percentage of doses of a drug taken correctly, as prescribed, for the required period of time, adherence is a combination of compliance and persistence, ie, the correct self-administration of treatment for the study period or treatment duration. The patient makes an informed decision about treatment and agrees this with the physician.
- Ad rotation
Advertising on a website that occupy one banner position and are displayed on rotation
- British National Formulary (BNF)
A national reference providing guidance on prescribing, dispensing and administering medicines in Britain
The process behind the movement of goods from manufacturer to customer. Includes a guide to planning, allocating, financial, human and purchasing operations
A market which contains only small amount of large buyers who make up the greatest share of purchases
- Accredited programmes
Learning modules that are assessed either by exam or by project-based assignments towards achieving a qualification or as part of continuing education programmes
The active support of a cause or course of action
- Data collection
The process of collecting market research data accomplished through interviewing or surveying
- Affiliate marketing
A form of marketing or advertising used on the internet. Companies that sell products or services online link to relevant sites. The advertising on the other or 'affiliate' sites is paid for according to results
- Boston matrix
A product portfolio evaluation tool developed by the Boston Consulting Group, the matrix categorises products into one of four classifications based on market growth and market share.
The four classifications are:
Cash cow – low growth, high market share
Star – high growth, high market share
Problem child – high growth, low market share
Dog – low growth, low market share
- Cost-effectiveness threshold (health economics)
The ceiling incremental cost-effectiveness ratio (ICER) beyond which interventions are no longer considered cost effective, reflecting the maximum value decision makers attach to health benefits. This may be stated in terms of cost per quality adjusted life year (QALY) gained